BOSS: The SLK-View Side Access Coronary Stent
Study of:
SLK-View Side Access stent; sponsored by Advanced Stent Technologies
The purpose of this study is to evaluate the safety and efficacy of SLK-View Side Access stent. Patients with bifurcation lesions will be eligible for enrollment and will receive this new stent. This new stent is designed for bifurcation lesions with an access hole for the purpose of treating the side branch vessel. Thirty-five clinical sites will enroll 330 patients. A subset of 100 patients will be required to return for a 6-month angiogram. Patients will be required to follow-up for a clinic visit at 1-month and again at 6-months. During each clinic visit, a physical exam and an electrocardiogram will be completed.
- M. Nicholas Burke, MD
- Timothy D. Henry, MD, FACC
- John R. Lesser, MD, FACC
- Daniel Lips, MD, FACC
- James D. Madison, MD, FACC
- Michael R. Mooney, MD, FACC
- Wesley R. Pedersen, MD, FACC
- Anil K. Poulose, MD, FACC
- Jay H. Traverse, MD, FACC, FAHA
- Yale Wang, MD, FACC, FSCAI
For more information about the interventional cardiology research program at the Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, please contact Carol Stone at 612-863-9124. |